Quantifying the impact of gut microbiota on inflammation and hypertensive organ damage
Cardiovascular Research · 13.06.2023 · 119 (6) · 1441-1452
DOI: 10.1093/cvr/cvac121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 29.07.2022. Verfasst von Ellen G Avery und 23 weiteren Autor:innen. Beteiligte Einrichtung: Experimental and Clinical Research Center, A Cooperation of Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Hypertension, Microbiota. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Research Council, Corona-Stiftung, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Aims
Hypertension (HTN) can lead to heart and kidney damage. The gut microbiota has been linked to HTN, although it is difficult to estimate its significance due to the variety of other features known to influence HTN. In the present study, we used germ-free (GF) and colonized (COL) littermate mice to quantify the impact of microbial colonization on organ damage in HTN. Methods and results 4-week-old male GF C57BL/6J littermates were randomized to remain GF or receive microbial colonization. HTN was induced by subcutaneous infusion with angiotensin (Ang) II (1.44 mg/kg/day) and 1% NaCl in the drinking water; sham-treated mice served as control. Renal damage was exacerbated in GF mice, whereas cardiac damage was more comparable between COL and GF, suggesting that the kidney is more sensitive to microbial influence. Multivariate analysis revealed a larger effect of HTN in GF mice. Serum metabolomics demonstrated that the colonization status influences circulating metabolites relevant to HTN. Importantly, GF mice were deficient in anti-inflammatory faecal short-chain fatty acids (SCFA). Flow cytometry showed that the microbiome has an impact on the induction of anti-hypertensive myeloid-derived suppressor cells and pro-inflammatory Th17 cells in HTN. In vitro inducibility of Th17 cells was significantly higher for cells isolated from GF than conventionally raised mice.
Conclusion
The microbial colonization status of mice had potent effects on their phenotypic response to a hypertensive stimulus, and the kidney is a highly microbiota-susceptible target organ in HTN. The magnitude of the pathogenic response in GF mice underscores the role of the microbiome in mediating inflammation in HTN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Experimental and Clinical Research Center, A Cooperation of Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
- Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
- DZHK (German Centre for Cardiovascular Research), partner site Berlin, Germany.
- Department of Biology, Chemistry, and Pharmacy, Freie Universität Berlin, Berlin, Germany.
- Department of Nephrology and Internal Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
ORCID-Profile: Ellen G Avery, Hendrik Bartolomaeus, Ariana Rauch, Chia-Yu Chen, Ulrike Löber, Theda U P Bartolomaeus, Raphaela Fritsche-Guenther, André F Rodrigues, Dmitry Tsvetkov, Mihail Todiras, Lajos Markó, Michael Bader, Stefan Kempa, Jennifer A Kirwan, Sofia K Forslund, Dominik N Müller, Nicola Wilck
Förderung
- European Research Council
- Corona-Stiftung
- Deutsche Forschungsgemeinschaft
- Berlin Institute of Health
Zitieren
APA
Avery, E. G., Bartolomaeus, H., Rauch, A., Chen, C. Y., N'Diaye, G., Löber, U., Bartolomaeus, T. U. P., Fritsche-Guenther, R., Rodrigues, A. F., Yarritu, A., Zhong, C., Fei, L., Tsvetkov, D., Todiras, M., Park, J. K., Markó, L., Maifeld, A., Patzak, A., Bader, M., …, & Wilck, N. (2023). Quantifying the impact of gut microbiota on inflammation and hypertensive organ damage. Cardiovascular Research, 119(6), 1441-1452. https://doi.org/10.1093/cvr/cvac121
Vancouver
Avery EG, Bartolomaeus H, Rauch A, Chen CY, N'Diaye G, Löber U, et al. Quantifying the impact of gut microbiota on inflammation and hypertensive organ damage. Cardiovascular Research. 2023;119(6):1441-1452. doi:10.1093/cvr/cvac121
BibTeX
@article{Avery2023,
author = {Avery, Ellen G and Bartolomaeus, Hendrik and Rauch, Ariana and Chen, Chia-Yu and N'Diaye, Gabriele and Löber, Ulrike and Bartolomaeus, Theda U P and Fritsche-Guenther, Raphaela and Rodrigues, André F and Yarritu, Alex and Zhong, Cheng and Fei, Lingyan and Tsvetkov, Dmitry and Todiras, Mihail and Park, Joon-Keun and Markó, Lajos and Maifeld, András and Patzak, Andreas and Bader, Michael and Kempa, Stefan and Kirwan, Jennifer A and Forslund, Sofia K and Müller, Dominik N and Wilck, Nicola},
title = {Quantifying the impact of gut microbiota on inflammation and hypertensive organ damage},
journal = {Cardiovascular Research},
year = {2023},
volume = {119},
number = {6},
pages = {1441--1452},
doi = {10.1093/cvr/cvac121}
}
EUVIMED